Keeping vials in their original packaging when not in use provides light protection
That is the real reason providers need to know about it when you start GLP-1 therapy
Additional evidence for an independent intrarenal RAS included observations that intrarenal ANG II contents markedly increased compared to circulating levels
Semaglutide (Ozempic/Wegovy) is a GLP-1 receptor agonist, while tirzepatide (Mounjaro/Zepbound) is a dual GIP/GLP-1 receptor agonist
Place under tongue and hold for 2 minutes before swallowing
and, Additional risks to watch out for when taking Ozempic include thyroid C-cell tumors, other thyroid issues, pancreatitis, diabetic retinopathy, acute kidney injury, hypersensitivity, acute gallbladder disease, hypoglycemia (when used with insulin/sulfonylurea), injection site reactions, and allergic reactions